| Literature DB >> 32280675 |
Jian-Hua Chen1, Nao-Xin Huang1, Tian-Xiu Zou1, Hua-Jun Chen1.
Abstract
OBJECTIVE: Fractal dimensionality (FD) analysis provides a quantitative description of brain structural complexity. The application of FD analysis has provided evidence of amyotrophic lateral sclerosis- (ALS-) related white matter degeneration. This study is aimed at evaluating, for the first time, FD alterations in a gray matter in ALS and determining its association with clinical parameters. Materials and Methods. This study included 22 patients diagnosed with ALS and 20 healthy subjects who underwent high-resolution T1-weighted imaging scanning. Disease severity was assessed using the revised ALS Functional Rating Scale (ALSFRS-R). The duration of symptoms and rate of disease progression were also assessed. The regional FD value was calculated by a computational anatomy toolbox and compared among groups. The relationship between cortical FD values and clinical parameters was evaluated by Spearman correlation analysis.Entities:
Mesh:
Year: 2020 PMID: 32280675 PMCID: PMC7115147 DOI: 10.1155/2020/1521679
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Demographic and clinical characteristics of the study participants in this study.
| Healthy controls ( | ALS patients ( |
| |
|---|---|---|---|
| Age (years) | 54.5 ± 5.5 | 57.2 ± 10.2 | 0.27 |
| Sex (males/females) | 12/8 | 15/7 | 0.58 |
| Site of onset (bulbar/cervical/thoracic/lumbosacral) | — | 4/11/1/6 | — |
| Diagnostic category (definite/probable/possible) | — | 5/6/11 | — |
| ALSFRS-R score | — | 39.7 ± 7.4 | — |
| Disease duration (months) | — | 13.5 ± 11.5 | — |
| Disease progression rate | — | 0.69 ± 0.45 | — |
ALS: amyotrophic lateral sclerosis; ALSFRS-R: revised ALS Functional Rating Scale. The rate of disease progression was calculated using the equation: (48-ALSFRS-R)/disease duration. “—” denotes no data available.
Figure 1The correlations between FD measurement and ALS patients' clinical parameters.